About Bioreba
Bioreba is a company based in Reinach (Switzerland) founded in 1980 was acquired by Calibre Scientific in January 2024. Bioreba offers products and services including qPCR Sets, ELISA Kits, AgriStrip Tests, and Extraction Bags. Bioreba operates in a competitive market with competitors including Inscripta, GenScript, Parse Biosciences, Biofidelity and OncoDNA, among others.
- Headquarter Reinach, Switzerland
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website bioreba.ch/bioreba.aspx
- Social LinkedIn Instagram YouTube
- Acquired by Calibre Scientific (Jan 2024)
- Legal Name Bioreba Ag
- Latest Funding Round$81.94K (USD), Grant
May 2018
- InvestorsCalibre Scientific
& 1 more
- Acquired byCalibre Scientific
(Jan 2024)
Products & Services of Bioreba
Bioreba offers a comprehensive portfolio of products and services, including qPCR Sets, ELISA Kits, AgriStrip Tests, and Extraction Bags.
Kits for detecting plant pathogens like viruses via PCR
Tests for identifying bacterial and viral plant diseases
Lateral flow tests for quick plant pathogen detection
Tools for efficient sample extraction in agro-diagnostics
Apps and channels of Bioreba
its YouTube channel BIOREBA AG has 91 subscribers and 18 videos.
Videos from Bioreba
The most watched videos on Bioreba's YouTube channel, BIOREBA AG (91 subscribers). Click a video to play it here.
More on BIOREBA AG.
Funding Insights of Bioreba
- Total Rounds 2
- Last Round Grant — $81,944
- First Round $28,420
(Jan 2017)
- Investors Count 1
All 2 funding rounds of Bioreba with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $81,944 | Grant | – | – | |
| Jan 2017 | $28,420 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Bioreba
Bioreba has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Calibre Scientific and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Provider of contract based research, manufacturing, distribution and other services for biopharma sector | 2016 | calibrescientific.com | Los Angeles, United States |
Investor details for Bioreba
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioreba
4 dated milestones of Bioreba across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Bioreba is founded.
- Funding First funding round of $28K.
- Funding Latest funding round, Grant, of $82K.
- Exit Acquired by Calibre Scientific.
Competitors of Bioreba
Bioreba operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, GenScript, Parse Biosciences, Biofidelity and OncoDNA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inscripta.io | 2015 | Helsinki, Finland | $853,384 | – | Speech recognition solutions are provided by Inscripta for healthcare professionals. | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| oncodna.com | 2012 | Charleroi, Belgium | $44.53M | 37 | Genomic and theranostic services for oncology precision medicine are delivered. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems |
Detailed competitors of Bioreba
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioreba
The website of Bioreba (bioreba.ch) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 33.3% vs previous month
Websites whose visitors overlap most with Bioreba. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| caliperls.com | 96% | – | – | View details | |
| whatman.com | 66% | – | – | View details | |
| specac.com | 63% | 39.4K | #825,512 | View details | |
| cpiinternational.com | 48% | 5.4K | #3,630,266 | View details |
Latest news on Bioreba
Complete news archive for Bioreba
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Bioreba
10 companies that operate in the same segment as Bioreba (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioreba
Bioreba was founded in 1980 and raised its 1st funding round 37 years after it was founded.
Bioreba is headquartered in Reinach, Switzerland. It is registered at Reinach, Basel-landschaft, Switzerland.
Bioreba was founded in 1980 in Reinach, Switzerland, and operates in the agricultural biotechnology sector. ELISA reagents for plant virus diagnostics are developed and marketed by the company, targeting research and laboratory needs. A range of products is provided for crops such as potatoes, grapevines, fruit trees, vegetables, and field crops. The lineup encompasses PCR macroarray extraction sets, ELISA buffers, chemicals, controls, AgriStrip tests, homogenizers, and disposables.
Bioreba's top competitors include Sino Biological, Qiagen and OncoDNA.
Bioreba offers qPCR Sets, ELISA Kits, AgriStrip Tests, and Extraction Bags.
Bioreba has 2 investors. Key investors include Calibre Scientific, and European Union.
Bioreba operates through Bioreba Ag.
Yes. Bioreba was acquired by Calibre Scientific in January 2024.